BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16985292)

  • 1. Development of a real-time PCR assay for detection of gyrA mutations associated with reduced susceptibility to ciprofloxacin in Salmonella enterica serovar typhi and paratyphi A.
    Morita M; Ito K; Hirose K; Takahashi H; Shimuta K; Terajima J; Ohnishi M; Harada M; Matsuzaki M; Watanabe H; Izumiya H
    Microbiol Immunol; 2006; 50(9):707-11. PubMed ID: 16985292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
    J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening method for Salmonella enterica serovar Typhi and serovar Paratyphi A with reduced susceptibility to fluoroquinolones by PCR-restriction fragment length polymorphism.
    Hirose K; Tamura K; Watanabe H
    Microbiol Immunol; 2003; 47(2):161-5. PubMed ID: 12680720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin.
    Misra R; Thakare R; Amrin N; Prasad KN; Chopra S; Dhole TN
    Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):472-9. PubMed ID: 27618918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
    Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH
    Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased susceptibility to fluoroquinolones and gyrA gene mutation in the Salmonella enterica serovar Typhi and Paratyphi A isolated in Katmandu, Nepal, in 2003.
    Shirakawa T; Acharya B; Kinoshita S; Kumagai S; Gotoh A; Kawabata M
    Diagn Microbiol Infect Dis; 2006 Apr; 54(4):299-303. PubMed ID: 16466897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LightCycler gyrA mutation assay (GAMA) identifies heterogeneity in GyrA in Salmonella enterica serotypes Typhi and Paratyphi A with decreased susceptibility to ciprofloxacin.
    Walker RA; Skinner JA; Ward LR; Threlfall EJ
    Int J Antimicrob Agents; 2003 Dec; 22(6):622-5. PubMed ID: 14659662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A.
    Renuka K; Kapil A; Kabra SK; Wig N; Das BK; Prasad VV; Chaudhry R; Seth P
    Microb Drug Resist; 2004; 10(2):146-53. PubMed ID: 15256030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of mutations in the gyrA gene in fluoroquinolone resistance Salmonella enterica serotypes typhi and paratyphi A isolated from the Infectious Diseases Hospital, Kuwait.
    Dimitrov T; Dashti AA; Albaksami O; Jadaon MM
    J Clin Pathol; 2010 Jan; 63(1):83-7. PubMed ID: 19889623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution melting assay for the detection of gyrA mutations causing quinolone resistance in Salmonella enterica serovars Typhi and Paratyphi.
    Slinger R; Bellfoy D; Desjardins M; Chan F
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):455-8. PubMed ID: 17156963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Salmonella enterica serovars Typhi and Paratyphi.
    Day MR; Doumith M; Do Nascimento V; Nair S; Ashton PM; Jenkins C; Dallman TJ; Stevens FJ; Freedman J; Hopkins KL; Woodford N; De Pinna EM; Godbole G
    J Antimicrob Chemother; 2018 Feb; 73(2):365-372. PubMed ID: 29216342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel restriction enzyme SSiI for the detection of mutation in GyrA gene of Salmonella enterica serovar Typhi.
    Agrawal P; Kapila K; Kumar S; Ghosh AN; Maurya AK
    Indian J Pathol Microbiol; 2010; 53(3):509-12. PubMed ID: 20699513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multiplex single nucleotide polymorphism typing assay for detecting mutations that result in decreased fluoroquinolone susceptibility in Salmonella enterica serovars Typhi and Paratyphi A.
    Song Y; Roumagnac P; Weill FX; Wain J; Dolecek C; Mazzoni CJ; Holt KE; Achtman M
    J Antimicrob Chemother; 2010 Aug; 65(8):1631-41. PubMed ID: 20511368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan.
    Lee CJ; Su LH; Huang YC; Chiu CH
    J Microbiol Immunol Infect; 2013 Dec; 46(6):469-73. PubMed ID: 23465712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multicountry Molecular Analysis of Salmonella enterica Serovar Typhi With Reduced Susceptibility to Ciprofloxacin in Sub-Saharan Africa.
    Al-Emran HM; Eibach D; Krumkamp R; Ali M; Baker S; Biggs HM; Bjerregaard-Andersen M; Breiman RF; Clemens JD; Crump JA; Cruz Espinoza LM; Deerin J; Dekker DM; Gassama Sow A; Hertz JT; Im J; Ibrango S; von Kalckreuth V; Kabore LP; Konings F; Løfberg SV; Meyer CG; Mintz ED; Montgomery JM; Olack B; Pak GD; Panzner U; Park SE; Razafindrabe JL; Rabezanahary H; Rakotondrainiarivelo JP; Rakotozandrindrainy R; Raminosoa TM; Schütt-Gerowitt H; Sampo E; Soura AB; Tall A; Warren M; Wierzba TF; May J; Marks F
    Clin Infect Dis; 2016 Mar; 62 Suppl 1(Suppl 1):S42-6. PubMed ID: 26933020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High level ciprofloxacin resistance in Salmonella enterica isolated from blood.
    Raveendran R; Wattal C; Sharma A; Oberoi JK; Prasad KJ; Datta S
    Indian J Med Microbiol; 2008; 26(1):50-3. PubMed ID: 18227598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing trends in the antibiograms of Salmonella isolates at a tertiary care hospital in Hyderabad.
    Lakshmi V; Ashok R; Susmita J; Shailaja VV
    Indian J Med Microbiol; 2006 Jan; 24(1):45-8. PubMed ID: 16505555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
    BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salmonella enterica serovar Typhi and S. Paratyphi A: need to expand the QRDR region?
    Walther-Rasmussen J; Høiby N
    Epidemiol Infect; 2011 Aug; 139(8):1281-3; author reply 1283. PubMed ID: 21050501
    [No Abstract]   [Full Text] [Related]  

  • 20. Changing trends in antimicrobial resistance of Salmonella enterica serovar typhi and salmonella enterica serovar paratyphi A in Chennai.
    Krishnan P; Stalin M; Balasubramanian S
    Indian J Pathol Microbiol; 2009; 52(4):505-8. PubMed ID: 19805957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.